
Leading thinking on biotechnology business management
The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up-to-date with current issues and industry trends.
Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:
- Management
- Policy
- Finance
- Law
- Regulation
- Bioethics
The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.
Vol 19, Issue 2 (2013)
Table of Contents
Commentary
| Capturing Value |
PDF
|
| G. Steven Burrill |
| Defining valuable information in a shifting industry |
PDF
|
| Andrew F Bourgoin |
| Commercial Biotechnology in Mexico |
PDF
|
| Minerva Valdes, Fernando Quezada |
Articles
| Technology Transfer: Bridging academic research and society – a communicative approach |
PDF
|
| Martin Vad Bennetzen, Lars Stig Møller |
| The financial ecosystem available to early-stage biotechnology firms and its misalignment with interests of these firms, of the biotechnology industry and with global disease burden |
PDF
|
| Gergely Toth |
| A Patient Centric Commercial Model for Cancer Care |
PDF
|
| Sanjay Rao |
| Developing Cell Therapies: Enabling cost prediction by value systems modeling to manage developmental risk. |
PDF
|
| Mark Joseph McCall, David John Williams |
| Challenges and prospects for monoclonal antibodies in China |
PDF
|
| Honghao Shi, Meiwan Chen, Yunzhen Shi, Hao Hu, Yitao Wang |
From the Boardroom
| A Business Perspective on IP: Open Innovation vs. Open Source in Commercializing Biotechnology |
PDF
|
| Arthur A. Boni |
| Getting Social with Biotechnology Business Development |
PDF
|
| Tim McCready |
Legal and Regulatory Updates
| Bowman v. Monsanto: Revisiting the Exhaustion Doctrine and its Application to Biotechnology and Digital Technologies |
PDF
|
| Susan Kling Finston |
| Should the HHS Decision to Overrule FDA on Plan B Be Reversed |
PDF
|
| Peter J. Pitts |
Copyright © thinkBiotech LLC








Follow on Twitter
RSS updates
Register for email updates